His pioneering work in the fields of gene cloning and expression of human proteins has been the basis for five significant marketed therapeutics developed by Genentech,
including human insulin, human growth hormone, interferon - alpha, interferon - gamma and tissue plasminogen activator.
Not exact matches
Some of the marketing material highlighted in Lion's cross claim
includes: «A2 will improve
human health through the consumption of a2 dairy milk products», «studies suggest that milk containing only the A2 type of protein may benefit you and your family if you're concerned with certain allergies, immune function or digestive wellbeing» and «there is significant evidence to suggest that beta casein A1 may be a primary risk factor for heart disease in adult men and also be involved in the progression of
insulin dependent diabetes in children... Beta casein A1... is the most powerful risk factor ever discovered.»
Other growth - promoting factors
including human milk growth factors I, II, and III (HMGF), and
insulin - like growth factor (IGF - I) have also been identified in
human breast milk.
The reason for this seems to be
insulin - like growth factor (IGF), a protein that is released by the liver of all animals (
humans included) in response to growth hormone.
Shamefully, accolades that resounded a generation ago for biotechnology advances — for instance, recombining DNA to develop
human - derived
insulin, which is much safer than the animal - derived products that came before — have been drowned out by a misinformed coalition of 114 organizations,
including ETC Group and Friends of the Earth.
After implantation, these cells are expected to become mature
human islet tissue
including well - regulated beta cells producing
insulin on demand.
Repair; The biology of aging convincingly shows nutrient sensors
including insulin for glucose and mTOR for protein, control a genetic pathway that is almost universally conserved among all animal life from single celled yeast onward to
humans.